These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9234945

  • 1. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
    Nahreini P, Mathews MB.
    Virology; 1997 Jul 21; 234(1):42-50. PubMed ID: 9234945
    [Abstract] [Full Text] [Related]

  • 2. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL, Santin AD, De Greve J, De Rijcke M, Bishop BM, Han L, Mane M, Kokorina N.
    J Hum Virol; 1999 Jul 21; 2(6):359-68. PubMed ID: 10774553
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 4. Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells.
    Tsunoda H, Hayakawa T, Sakuragawa N, Koyama H.
    Virology; 2000 Mar 15; 268(2):391-401. PubMed ID: 10704347
    [Abstract] [Full Text] [Related]

  • 5. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.
    Kearns WG, Afione SA, Fulmer SB, Pang MC, Erikson D, Egan M, Landrum MJ, Flotte TR, Cutting GR.
    Gene Ther; 1996 Sep 15; 3(9):748-55. PubMed ID: 8875221
    [Abstract] [Full Text] [Related]

  • 6. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M, Rimessi P, Sabbioni S, Caputo A, Balboni PG, Gualandri R, Manservigi R, Grossi MP, Barbanti-Brodano G.
    Biotechniques; 1991 Mar 15; 10(3):344-53. PubMed ID: 1829615
    [Abstract] [Full Text] [Related]

  • 7. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A, Perani L, Sartori D, Olgiati C, Mavilio F.
    Mol Ther; 2004 Oct 15; 10(4):660-70. PubMed ID: 15451450
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
    Brdar B, Matulić M, Rubelj I, Ivanković M, Reich E.
    Croat Med J; 2002 Oct 15; 43(5):591-7. PubMed ID: 12402403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene.
    Shelling AN, Smith MG.
    Gene Ther; 1994 May 15; 1(3):165-9. PubMed ID: 7584077
    [Abstract] [Full Text] [Related]

  • 15. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
    Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F.
    Virology; 2000 Nov 25; 277(2):278-95. PubMed ID: 11080476
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J, Kräusslich HG.
    FEBS Lett; 2004 Apr 09; 563(1-3):113-8. PubMed ID: 15063733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C, Chen Y, Park J, Kim JB, Tang H.
    Biochem Biophys Res Commun; 2004 Sep 17; 322(2):614-22. PubMed ID: 15325274
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.